protein kinase C inhibitors (Medisyn)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameprotein kinase C inhibitors (Medisyn)
Drug Alias NameMT-103 (Medisyn)MIT-103
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors modulatorsApoptosis stimulantsProtein kinase C alpha inhibitors +[4] 
TargetsEstrogen receptorsProtein kinase C alpha
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedisyn Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedisyn Technologies Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A